Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 2867-2871

  Alcaide, Fernando ^a   Galí, Nuria ^b   Domínguez, José ^b   Berlanga, Pilar ^a   Blanco, Silvia ^b   Orús, Pilar ^a   Martín, Rogelio ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AURAMINE; FLUOROCHROME; RHODAMINE;

ACID FAST BACTERIUM; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GRAM STAINING; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIOPHAGE BASED TECHNIQUE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SMEAR;

COLONY COUNT, MICROBIAL; CULTURE MEDIA; HUMANS; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; PLAQUE ASSAY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS, PULMONARY;

ACTINOBACTERIA (CLASS); BACILLI; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; MYCOBACTERIUM XENOPI; UNCULTURED ACTINOMYCETE;

EID: 0038507237     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.2867-2871.2003     Document Type: Article

References (29)

1. Albert, H., A. Heydenrych, R. Brookes, R. J. Mole, B. Harley, E. Subotsky, R. Henry, and V. Azevedo. 2002. Performance of a rapid phage-based test, FASTPlaqueTB™, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int. J. Tuberc. Lung Dis. 6:529-537.
2. Alcaide, F., I. Richter, C. Bernasconi, B. Springer, C. Hagenau, R. Schulze-Röbbecke, E. Tortoli, R. Martin, E. C. Böttger, and A. Telenti. 1997. Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J. Clin. Microbiol. 35:1959-1964.
3. Banaiee, N., M. Bobadilla-Del-Valle, S. Bardarov, Jr., P. F. Riska, P. M. Small, A. Ponce-De-Leon, W. R. Jacobs, Jr., G. F. Hatfull, and J. Sifuentes-Osornio. 2001. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J. Clin. Microbiol. 39:3883-3888.
4. Carriere, C., P. F. Riska, O. Zimhony, J. Kriakov, S. Bardarov, J. Burns, J. Chan, and W. R. Jacobs, Jr. 1997. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 35:3232-3239.
5. Colebunders, R., and I. Bastian. 2000. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 4:97-107.
6. Eltringham, I. J., F. A. Drobniewski, J. A. Mangan, P. D. Butcher, and S. M. Wilson. 1999. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 37:3524-3527.
7. Eltringham, I. J., S. M. Wilson, and F. A. Drobniewski. 1999. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 37:3528-3532.
8. Falkinham, J. O., III. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 9:177-215.
9. Falloon, J. 2000. Pulmonary manifestations of human inmunodeficiency virus infection, p. 1415-1426. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th ed. Churchill Livingstone, New York, N.Y.
10. Foulds, H., and R. O'Brien. 1998. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int. J. Tuberc. Lung Dis. 2:778-783.
11. Froman, S., D. W. Will, and E. Bogen. 1954. Bacteriophage active against virulent Mycobacterium tuberculosis. I. Isolation and activity. Am. J. Public Health 44:1326-1333.
12. Galen, R. S., and S. R. Gambino. 1975. Beyond normality: the predictive value and efficiency of medical diagnosis. John Wiley & Sons, New York, N.Y.
13. Gardner, G. M., and R. S. Weiser. 1947. A bacteriophage for Mycobacterium smegmatis. Proc. Soc. Exp. Biol. Med. 66:205-206.
14. Jacobs, W. R., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. J. Sarkis, G. F. Hatfull, and B. R. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
15. Kochi, A. 1991. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1-6.
16. Kubica, G. P., W. E. Dye, M. L. Cohn, and G. Middlebrook. 1963. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am. Rev. Respir. Dis. 87:775-779.
17. Long, R. 2001. Smear-negative pulmonary tuberculosis in industrialized countries. Chest 120:330-334.
18. Mole, R. J., and T. W. O. Maskell. 2001. Phage as a diagnostic - the use of phage in TB diagnosis. J. Chem. Technol. Biotechnol. 76:683-688.
19. Muzaffar, R., S. Batool, F. Aziz, A. Naqvi, and A. Rizvi. 2002. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int. J. Tuberc. Lung Dis. 6:635-640.
20. Narain, J. P., M. C. Raviglione, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber. Lung Dis. 73:311-321.
21. Pearson, R. E., S. Jurgensen, G. J. Sarkis, G. F. Hatfull, and W. R. Jacobs, Jr. 1996. Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria. Gene 183:129-136.
22. Perkins, M. D. 2000. New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis. 4:S182-S188.
23. Picardeau, M., G. Prod'Hom, L. Raskine, M. P. LePennec, and V. Vincent. 1997. Genotypic characterization of five subspecies of Mycobacterium kansasii. J. Clin. Microbiol. 35:25-32.
24. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
25. Redmond, W. B., and J. C. Cater. 1960. A bacteriophage specific for Mycobacterium tuberculosis varieties hominis and bovis. Am. Rev. Respir. Dis. 82:781-786.
26. Richter, E., S. Niemann, S. Rüsch-Gerdes, and S. Hoffner. 1999. Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques. J. Clin. Microbiol. 37:964-970.
27. Riska, P. F., W. R. Jacobs, Jr., B. R. Bloom, J. McKitrick, and J. Chan. 1997. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-α-acetylamino-β-hydroxy propiophenone. J. Clin. Microbiol. 35:3225-3231.
28. Wilson, S. M., Z. al-Suwaidi, R. McNerney, J. Porter, and F. A. Drobniewski. 1997. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat. Med. 3:465-468.
29. World Health Organization. 2002. Global tuberculosis control: surveillance, planning, financing. WHO report 2002. WHO/CDS/TB/2002.295. World Health Organization, Geneva, Switzerland.